GAM
AVIR icon

Gotham Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History

Gotham Asset Management’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,431
Closed -$65K – 1209
2022
Q3 		$65K Sell
11,431
-10,622
-48% -$81.3K ﹤0.01% 1142
2022
Q2 		$157K Sell
22,053
-9,201
-29% -$62.8K 0.01% 1053
2022
Q1 		$226K Buy
31,254
+2,070
+7% +$14.1K 0.01% 1038
2021
Q4 		$261K Sell
29,184
-14,911
-34% -$232K 0.01% 994
2021
Q3 		$1.55M Buy
44,095
+21,730
+97% +$603K 0.06% 371
2021
Q2 		$480K Buy
+22,365
New +$672K 0.02% 693

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Gotham Asset Management's AVIR Position: Q4 2022 in Review

Gotham Asset Management sold out of Atea Pharmaceuticals (AVIR) in Q4 2022, closing a stake of 11,431 shares — an estimated $65K sold.

Gotham Asset Management first reported a position in AVIR in Q2 2021 and held it in 6 quarters. The position peaked at $1.55M in Q3 2021. 131 funds tracked by Wall St. Rank hold AVIR as of Q4 2022.

  • Gotham Asset Management reported no remaining Atea Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Gotham Asset Management sold 11,431 Atea Pharmaceuticals shares in Q4 2022, an estimated $65K.
  • Gotham Asset Management first reported a position in Atea Pharmaceuticals in Q2 2021 and held it in 6 quarters.
  • Gotham Asset Management's Atea Pharmaceuticals position peaked at $1.55M in Q3 2021.
  • 131 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q4 2022.

Based on Gotham Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.